Results 131 to 140 of about 9,802 (262)
Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female
Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecrosis of the jaw, may be associated with long-term use of bisphosphonates.
Bi-Wei Jan +4 more
doaj +1 more source
Oral toxicity produced by chemotherapy: A systematic review [PDF]
Introduction: Antineoplastic chemotherapy remains one of the most widely used management strategies in cancer, either alone or in combination with other types of treatment.
Chaveli López, Begonya
core +1 more source
Criteria for the prescription of oral bisphosphonates for the treatment of osteoporosis in a series of women referred for tooth extraction [PDF]
Objective: To evaluate the criteria for the prescription of oral bisphosphonates (OB) in a series of women with osteoporosis referred for tooth extraction.
Diniz Freitas, Márcio +5 more
core +1 more source
The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. [PDF]
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) has generated great interest in the medical and research communities yet remains an enigma, given its unknown pathogenesis.
Allen, Matthew R., Burr, David B.
core +1 more source
Licia Manzon,1 Evaristo Ettorre,1 Giovanni Viscogliosi,1 Stefano Ippoliti,1 Fabio Filiaci,2 Claudio Ungari,2 Giovanni Fratto,1 Alessandro Agrillo2 1Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences ...
Manzon L +7 more
doaj
Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw - Prognostic factors in the treatment of BRONJ - [PDF]
Objectives: Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a relatively rare but serious side effect of bisphosphonate (BP)-based treatments. This retrospective study aimed to investigate the risk factors and predictive markers in cases where
Kaneuji, Takeshi +13 more
core +1 more source
Background: Medication-related osteonecrosis of the jaw (MRONJ) is a rare, but significant adverse event primarily associated with the intake of antiresorptive and antiangiogenic medications.
Rahul Mohandas +3 more
doaj +1 more source
Introduction: Medication-related osteonecrosis of the jaw (MRONJ) is an important uncommon complication. Due to its complexity, its prevention requires a multidisciplinary approach, involving physicians and dental clinicians.
Tahereh Padeganeh +3 more
doaj
Osteoquimionecrosis de los maxilares asociada a la administración de bifosfonatos por vía endovenosa: a propósito de seis casos [PDF]
La osteonecrosis de los maxilares en pacientes con cáncer se asociaba, hasta ahora, con la radioterapia, aunque recientemente se han reportado numerosos casos de osteoquimionecrosis de los maxilares (OQNM) relacionada con la quimioterapia, y más ...
Berini Aytés, Leonardo +3 more
core
Medication-related osteonecrosis of the jaw is a rare but severe complication with challenging treatment protocols. Cold atmospheric plasma (CAP) has shown promising effects in wound healing, cell proliferation and viability.
Zahra Rahati Ghuchani +2 more
doaj +1 more source

